Literature DB >> 20189334

Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.

A Haennig, D Bonnet, S Thebault, L Alric.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189334     DOI: 10.1016/j.gcb.2010.01.016

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


× No keyword cloud information.
  8 in total

1.  Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case.

Authors:  Dahlia A Goldfeld; Elizabeth C Verna; Jay Lefkowitch; Arun Swaminath
Journal:  Dig Dis Sci       Date:  2011-05-20       Impact factor: 3.199

2.  Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.

Authors:  Susana Rodrigues; Susana Lopes; Fernando Magro; Hélder Cardoso; Ana Maria Horta e Vale; Margarida Marques; Eva Mariz; Miguel Bernardes; Joanne Lopes; Fátima Carneiro; Guilherme Macedo
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 3.  Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.

Authors:  Roberta Elisa Rossi; Ioanna Parisi; Edward John Despott; Andrew Kenneth Burroughs; James O'Beirne; Dario Conte; Mark Ian Hamilton; Charles Daniel Murray
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 4.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors:  Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

Review 5.  Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.

Authors:  Loris Riccardo Lopetuso; Giammarco Mocci; Manuela Marzo; Francesca D'Aversa; Gian Lodovico Rapaccini; Luisa Guidi; Alessandro Armuzzi; Antonio Gasbarrini; Alfredo Papa
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

Review 6.  Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.

Authors:  Parth Shah; Vinay Sundaram; Einar Björnsson
Journal:  Hepatol Commun       Date:  2020-01-02

7.  Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature.

Authors:  Ravish Parekh; Nirmal Kaur
Journal:  Case Rep Gastrointest Med       Date:  2014-01-19

8.  Infliximab-induced autoimmune hepatitis requiring liver transplantation.

Authors:  Frederick Wong; Bashaar Al Ibrahim; Joanna Walsh; Karim Qumosani
Journal:  Clin Case Rep       Date:  2019-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.